🕵️ 60 Degrees Pharmaceuticals, Inc. ($SXTP)
SEC insider & ownership activity, last 12 months · CIK 1946563 · every row links its SEC filing
Over the last 12 months insiders bought $30K with no open-market selling against it. Geoffrey S. Dow bought $30K (Dec–Jun). One red-flag 8-K in the window: Delisting notice (3.01), Jan 20, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $30K (4 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Geoffrey S. Dow | 4 | $30K | 0 | – | Jun 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Knight Therapeutics Inc. | 19.9% | 13G | Jul 29, 2026 | filing ↗ | |
| Mitchell P. Kopin | 9.1% | 13G | May 13, 2026 | filing ↗ | |
| Daniel B. Asher | 9.1% | 13G | May 13, 2026 | filing ↗ | |
| Intracoastal Capital LLC | 9.1% | 13G | May 13, 2026 | filing ↗ | |
| CVI Investments, Inc. | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| Heights Capital Management, Inc. | 7.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Other events (8.01) | Jul 7, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 13, 2026 | filing ↗ |
| Other events (8.01) | Mar 20, 2026 | filing ↗ |
| Other events (8.01) | Mar 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 13, 2026 | filing ↗ |
| Other events (8.01) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Feb 11, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 20, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jan 14, 2026 | filing ↗ |
| Other events (8.01) | Jan 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | Oct 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 3, 2025 | filing ↗ |
| Agreement terminated (1.02) | Sep 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2025 | filing ↗ |